CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

BYD COMPANY (01211.HK) toppled Toyota for the first time in 2024 to become the most popular car brand in Singapore, foreign ...

Taking a more bearish stance, CLSA has downgraded HUL to an Underperform rating. The brokerage firm also has slashed its ...

Kanzhun Limited (NASDAQ:BZ – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat reports. Four investment ...

The third-quarter earnings season is in full swing, with around 59 companies set to release their results on Thursday.

There is mild anticipation that as the Snake year slithers in, the local IPO markets will open up, and the STI will hit a new ...

SK Hynix Inc.’s shares slid 4.7% after its record quarterly profit and modest capex plans failed to impress investors betting ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

Out of the 43 analysts that now have coverage on HUL, 27 of them have maintained a 'Buy' rating on the stock, while 13 of ...

In a report released on January 21, Garry Sherriff from RBC Capital maintained a Hold rating on Pro Medicus Limited (PMCUF – Research Report), ...